A recent CDC report indicates that one-third of US adults do not have the recommended knowledge of stroke symptoms. Do you find that your patients often have the recommended knowledge of the signs of stroke? Share your experience in our latest poll.
In the THALES randomized clinical trial, investigators compared the effects of aspirin plus ticagrelor vs aspirin alone in reducing disabling recurrent stroke among patients with minor ischemic stroke or transient ischemic attack.
A new CDC report indicates that a significant proportion of US adults do not have the recommended knowledge of stroke symptoms, highlighting significant disparities in this area.
The authors of a new study published in Stroke investigated whether apical lung assessment on computed tomography angiography, which is performed among patients with acute ischemic stroke, could also identify possible COVID-19 among these patients.
In a randomized study, researchers investigated whether using a stroke alarm clock that demands active feedback from stroke physicians could help accelerate acute stroke care.
ICH: Intensive SBP Reduction May Be Tied to Neurological Deterioration Among Patients With Excessively High Initial SBP
In a recent analysis, researchers aimed to compare outcomes associated with intensive vs standard systolic blood pressure reduction among patients with intracerebral hemorrhage with excessively high initial systolic blood pressure.
In a recent study, researchers aimed to investigate whether cigarette smoking affected all-cause incident stroke among Black people, who are disproportionately impacted by stroke compared with white people.
Researchers investigated whether shorter door-to-needle times were associated with improved long-term outcomes among more than 61,000 Medicare beneficiaries aged 65 years or older who were treated for acute ischemic stroke.
Findings from a new retrospective cohort study published in the journal Stroke shed light on the rate of strokes among patients with COVID-19 in New York.
Researchers used data from 7 observational studies to evaluate the impact of glucose status on cognitive performance at 3 to 6 months after stroke among patients with normal fasting glucose, impaired fasting glucose, or type 2 diabetes.